Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.
Related Posts
Entain Online Gaming Revenue Tops Forecasts
Entain said its online net gaming revenue has grown ahead of expectations so far in the second half of year, with the positive momentum of […]
NASA to Assign Lunar Delivery Missions to SpaceX and Blue Origin
The agency says the companies would supply landers that would carry equipment and infrastructure to the moon’s surface.
British Land Expects Retail Park Boost as Shops Seek Cheaper Space
British Land expects more shops to move to retail parks to offset anticipated higher costs following the U.K. government’s budget last month.